Neurenati

Biotech company focused on developing therapies for rare diseases, with a current focus on Hirschsprung disease

placeMontreal, Quebec, Canada calendar_todayFounded 2020 language neurenati.com

Social engagement

Social engagement: 746 social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

29 Apr 2026
Event
Supplet Biopharma Day 2026
Coming soon